Kate Simpson

448 total citations
16 papers, 350 citations indexed

About

Kate Simpson is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Kate Simpson has authored 16 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Epidemiology. Recurrent topics in Kate Simpson's work include MicroRNA in disease regulation (6 papers), Extracellular vesicles in disease (4 papers) and Inflammatory Bowel Disease (3 papers). Kate Simpson is often cited by papers focused on MicroRNA in disease regulation (6 papers), Extracellular vesicles in disease (4 papers) and Inflammatory Bowel Disease (3 papers). Kate Simpson collaborates with scholars based in United Kingdom, United States and Canada. Kate Simpson's co-authors include Donald Fraser, Timothy Bowen, Alexa Wonnacott, Lucy J. Newbury, Robert L. Jenkins, Duncan M. Baird, Robert K. Hills, Julia W. Grimstead, Chris Pepper and Usman Khalid and has published in prestigious journals such as Scientific Reports, Kidney International and American Journal Of Pathology.

In The Last Decade

Kate Simpson

16 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kate Simpson United Kingdom	9	208	160	63	39	35	16	350
WenXing Fan China	11	194 0.9×	130 0.8×	46 0.7×	20 0.5×	42 1.2×	25	313
Kristian Scherf Germany	5	286 1.4×	251 1.6×	80 1.3×	44 1.1×	19 0.5×	5	440
Zhenghai Bai China	12	173 0.8×	150 0.9×	51 0.8×	62 1.6×	45 1.3×	23	344
Aradhana Mohan United States	8	331 1.6×	152 0.9×	85 1.3×	33 0.8×	69 2.0×	11	428
Shenglei Zhang China	12	161 0.8×	56 0.3×	94 1.5×	43 1.1×	67 1.9×	43	348
Lama Noureddine United States	11	202 1.0×	79 0.5×	104 1.7×	59 1.5×	51 1.5×	20	389
Toshimi Imai Japan	9	134 0.6×	55 0.3×	76 1.2×	113 2.9×	70 2.0×	30	340
Andrés Carmona Spain	9	172 0.8×	59 0.4×	128 2.0×	18 0.5×	29 0.8×	18	321
Jielu Hao United States	10	251 1.2×	183 1.1×	151 2.4×	54 1.4×	23 0.7×	16	466
Maocai Luo China	6	149 0.7×	42 0.3×	52 0.8×	21 0.5×	43 1.2×	15	299

Countries citing papers authored by Kate Simpson

Since Specialization

Citations

This map shows the geographic impact of Kate Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Simpson more than expected).

Fields of papers citing papers by Kate Simpson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Simpson. The network helps show where Kate Simpson may publish in the future.

Co-authorship network of co-authors of Kate Simpson

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Simpson. A scholar is included among the top collaborators of Kate Simpson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Simpson. Kate Simpson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Fragkos, Konstantinos C., Ana Lisboa, Kate Simpson, et al.. (2023). Two-year real-world outcome data from a single tertiary centre shows reduced ustekinumab persistence in a non-bio-naïve Crohn’s disease cohort with penetrating disease, -ostomies and sarcopenia. Therapeutic Advances in Chronic Disease. 14. 384237648–384237648. 1 indexed citations

Simpson, Kate, et al.. (2023). Does sarcopenia impact postoperative outcomes in Crohn’s disease patients?. Clinical Nutrition ESPEN. 58. 701–701. 1 indexed citations

Shankar, Ananth, Tom Kurzawinski, Emma Ross, et al.. (2021). Treatment outcome with a selective RET tyrosine kinase inhibitor selpercatinib in children with multiple endocrine neoplasia type 2 and advanced medullary thyroid carcinoma. European Journal of Cancer. 158. 38–46. 14 indexed citations

Newbury, Lucy J., Kate Simpson, Usman Khalid, et al.. (2021). miR-141 mediates recovery from acute kidney injury. Scientific Reports. 11(1). 16499–16499. 8 indexed citations

Smith, Daniel, Kate Simpson, Lucy J. Newbury, et al.. (2021). Detection of urinary microRNA biomarkers using diazo sulfonamide-modified screen printed carbon electrodes. RSC Advances. 11(31). 18832–18839. 15 indexed citations

Osterman, Mark T., Kelli L. VanDussen, Ilyssa O. Gordon, et al.. (2020). Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease. Inflammatory Bowel Diseases. 27(5). 677–685. 9 indexed citations

Newbury, Lucy J., Alexa Wonnacott, Kate Simpson, Timothy Bowen, & Donald Fraser. (2019). Assessment of Urinary MicroRNAs by Quantitative Polymerase Chain Reaction in Diabetic Nephropathy Patients. Methods in molecular biology. 2067. 277–285. 3 indexed citations

Khalid, Usman, Lucy J. Newbury, Kate Simpson, et al.. (2019). A urinary microRNA panel that is an early predictive biomarker of delayed graft function following kidney transplantation. Scientific Reports. 9(1). 3584–3584. 37 indexed citations

Beltrami, Cristina, Kate Simpson, Mark Jesky, et al.. (2018). Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease. American Journal Of Pathology. 188(9). 1982–1992. 66 indexed citations

10.

Danson, Sarah, Penella J. Woll, John Edwards, et al.. (2017). Oncolytic herpesvirus therapy for mesothelioma: A phase I/IIa trial of intrapleural administration of HSV1716 (NCT01721018). Annals of Oncology. 28. v122–v122. 8 indexed citations

11.

Simpson, Kate, Alexa Wonnacott, Donald Fraser, & Timothy Bowen. (2016). MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy. Current Diabetes Reports. 16(3). 35–35. 119 indexed citations

12.

Simpson, Kate, et al.. (2015). Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients. Molecular Oncology. 9(6). 1186–1193. 34 indexed citations

13.

Simpson, Kate, et al.. (2000). Serum creatinine can predict adequacy of peritoneal dialysis--preliminary report.. PubMed. 54(5). 400–3. 3 indexed citations

14.

Simpson, Kate, et al.. (1996). Multiple-Dose Pharmacokinetics of Pentoxifylline and its Metabolites during Renal Insufficiency. Annals of Pharmacotherapy. 30(7-8). 724–729. 20 indexed citations

15.

Simpson, Kate, et al.. (1986). Hemodialysis-related porphyria cutanea tarda--treatment failure with charcoal hemoperfusion.. PubMed. 3(3). 169–73. 10 indexed citations

16.

DiPette, Donald J., Alan J. Watson, & Kate Simpson. (1983). Diminished baro receptor function and vascular responsiveness in chronic renal failure in the intact awake rat. Kidney International. 23(1). 213. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact